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http://dx.doi.org/10.1016/j.stem.2013.01.002Information on the provenance of human
embryonic stem cells (hESCs) is critical
for both scientific and ethical reasons.
The genetic origin is important for select-
ing appropriate hESC lines for proposed
research, and the consent terms may
determine whether they can be used in
subsequent studies, clinical trials, or
development of therapeutics. From an
ethics perspective, requiring informed
consent is one crucial way to show
respect for persons who may not support
hESC research. Further, information
about how the embryos were created
and who consented to their use in
research is essential to the reviews and
approvals that many institutions, funders,
and regulators require prior to initiation of
what is still controversial research. As
such, it is surprising that not all providers
of hESC lines, including lines listed on
the National Institutes of Health (NIH)
Registry, ensure that full provenance in-
formation is readily and publicly available.
In2009, theNIH issuedguidelines (http://
stemcells.nih.gov/policy/2009guidelines)
for federal funding of hESC research
that require that the cells be derived
from embryos originally created by
in vitro fertilization (IVF) for reproductive
purposes that are no longer needed
for that purpose. The individual(s) who
sought reproductive treatment must give
informed consent for the embryos to
be used to derive hESCs for research
purposes. The NIH Guidelines make no
mention of the possibility that some
embryos will have been created using
donor gametes and do not require
consent from the gamete donor to use
the resulting embryos in research, a prob-
lematic omission that was noted when the
draft Guidelines were released (Majumder
and Cohen, 2009).
On this issue, the NIH Guidelines
conflict with national and international
guidelines that most hESC researchersin the US have been following for 7 years.
Guidelines from both the National
Academies of Science (National Research
Council and Institute of Medicine, 2005)
and the International Society for Stem
Cell Research (International Society for
Stem Cell Research, 2006) require the
informed consent of gamete donors
before embryos can be used in hESC
research. Some state funding agencies
do the same. The NAS Guidelines,
amended in 2007, 2008, and 2010
(National Research Council and Institute
of Medicine, 2007, 2008, 2010), have
been particularly influential. The 2010
Amendments call for written consent
specifically to the generation of hESCs
when gametes are donated for research
purposes, but allow that, when gametes
were donated for reproductive purposes,
written agreement for subsequent
‘‘embryo research’’ is sufficient (National
Research Council and Institute of Medi-
cine, 2010).
In response to these recommenda-
tions, many institutions have formed
Embryonic Stem Cell Research Oversight
(ESCRO) committees to review hESC
research. Insofar as they are adhering to
the NAS Guidelines, ESCRO committees
approve research only if consent to use
of the embryo in hESC research was
obtained from the embryo donors and
if a minimum of generic consent for
research use was obtained from any
oocyte or sperm donors. Unfortunately,
determining whether these consents
were obtained can be difficult.
The Tri-Institutional Stem Cell Initiative
(Tri-SCI) ESCRO Committee, which over-
sees hESC research at Memorial Sloan
Kettering Cancer Center, The Rockefeller
University, and Weill Cornell Medical
College, established procedures in 2006
for review of hESC research that are very
closely aligned with the NAS and, since
2009, NIH Guidelines. Because theseCell Stem Cell 12two sets of guidelines do not agree on
the issue of gamete donor consent, the
Committee continues to apply the stricter
NAS standard.
For the first few years of the Tri-SCI
ESCRO’s operation, it assumed that
hESC lines listed on the 2001NIH Registry
were obtained with the informed consent
of embryo and gamete donors. This
assumption was strengthened when the
2007 Amendments to the NAS Guidelines
deemed these lines acceptable for use
(National Research Council and Institute
of Medicine, 2007). However, when a
2008 study reported problems with
some of the consent forms used for
donation of embryos from which 2001
NIH Registry hESC lines were derived
(Streiffer, 2008), the Tri-SCI ESCRO pro-
hibited use of four particular lines.
Last year, the Tri-SCI ESCRO was
moved to request an examination of the
provenance of the current NIH Registry
lines when another study reported that
just 30% of oocyte donor consent forms
in surveyed US IVF clinics mention the
possibility that resultant embryos might
be donated to research, and only 8%
mention donation to hESC research
specifically (Schaefer et al., 2012).
As a first step, we reviewed the NIH
Registry website and the line providers’
websites and found gamete donor pro-
venance information for 48 of the
198 current lines. For the remaining 150
lines, we made direct requests to the
providers and obtained provenance infor-
mation for an additional 131 lines. We
therefore have information for 179 of the
198 lines.
From the information we received, we
determined that for 104 lines, the embryo
donors were the gamete providers. For
eight additional lines, donor gametes
were definitely used and in six of these
cases, we were able to determine that
the gamete donors gave generic consent, February 7, 2013 ª2013 Elsevier Inc. 147
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whether donated gametes were used for
the other 67 lines, but we obtained
assurances from the providers of 33
of these that, if third party gametes
were involved, the consent form for
gamete donation would have included
reference to possible donation of resul-
tant embryos for derivation of hESCs.
For an additional four lines, the providers
told us that generic consent for research
would have been obtained from any
gamete donors.
This leaves 30 lines for which the
providers say they do not know whether
gamete donors were involved and
whether they provided consent for
research (generic or specific to hESC
research). In total, we are satisfied that
137 of the 198 lines currently listed in
the NIH Registry meet our requirement
that all individuals whose gametes were
used provided written consent specifi-
cally for hESC research. For an additional
ten lines, we are satisfied that gamete
donors provided a general consent to
research use.
Given the steady pace at which new
lines are added to the NIH Registry, these
numbers will soon be out of date. Yet, our148 Cell Stem Cell 12, February 7, 2013 ª201general findings will likely remain. (1)
Some NIH Registry lines were derived
from embryos created using donor
gametes. (2) Not all of these gamete
donors provided specific consent for deri-
vation of hESCs from resultant embryos.
(3) Obtaining information about gamete
donor consent is difficult.
With such rapid advances occurring in
stem cell research, it is critical that
consent forms for donation of gametes
to IVF refer not just to the possibility of
future research use, but also to derivation
of hESCs specifically. Also, information
about the provenance of the hESC lines
should be public and readily available.
The hESC research community will be
best served if their essential research
materials—gametes and embryos —are
donated by individuals who knowingly
and willingly agree to the use of those
materials in hESC research.
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